Drug Trial Radar · NCT03619850
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
129
Planned (sponsor's estimate)
Start
Aug 13, 2018
Primary completion
Aug 31, 2026
Study completion Aug 31, 2026
Sponsor
- Lead sponsor
- AMAG Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 8, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objectives: To evaluate the safety (compared to iron sucrose) and efficacy of ferumoxytol in pediatric CKD subjects with iron deficiency anemia (IDA) or who are at risk of development of IDA Secondary Objective: To determine the single-dose pharmacokinetics (PK) and pharmacodynamics (PD) profile of ferumoxytol in pediatric subjects.
Conditions
- Chronic Kidney Disease; Iron Deficiency Anemia
Interventions
FerumoxytolDrug
Each 20 mL single-use vial contains 17 mL of ferumoxytol that consists of iron at a concentration of 30 mg Fe/mL, coated with polyglucose sorbitol carboxymethylether and formulated with mannitol, at a concentration of 44 mg/mL, in a black to reddish brown sterile, aqueous, colloidal, isotonic solution.
Iron sucroseDrug
Each mL contains 20 mg of elemental iron as iron sucrose in water for injection. The 5 mL single-use vial contains 100 mg of iron per 5 mL. The drug product contains approximately 30% sucrose (300 mg/mL).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hemoglobin change of at least 0.5 g/dL from Baseline to Week 5Time frame: 35 days
Locations
21 sites in 5 countries. Site status is shown where the registry gives one.
Memorial Healthcare System
Hollywood, Florida · Not yet recruiting
Wayne State University
Detroit, Michigan · Active not recruiting
Children's Mercy Hospital
Kansas City, Missouri · Recruiting
The Feinstein Institute Medical Research Organization of Northwell Health, Inc.
Lake Success, New York · Not yet recruiting
Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH)
New York, New York · Active not recruiting
Montefiore Medical Center (MMC) - The Children's Hospital at Montefiore (CHAM)
The Bronx, New York · Recruiting
Akron Nephrology Associates, Inc.
Akron, Ohio · Recruiting
West Virginia University
Morgantown, West Virginia · Recruiting
Semmelweis Egyetem - Altalanos Orvostudomanyi Kar (SE AOK) - I. sz. Gyermekgyogyaszati Klinika
Budapest, Hungary · Recruiting
University Of Szeged
Szeged, Hungary · Recruiting
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, Lithuania · Not yet recruiting
Klaipeda Children's Hospital
Klaipėda, Lithuania · Active not recruiting
Vsl Vilniaus Universiteto Vaiku Ligonine (VUVL) (Vilnius University Children's Hospital)
Vilnius, Lithuania · Not yet recruiting
Instituto Mexicano De Trasplantes S.C
Cuernavaca, Mexico · Recruiting
JM Research, SC
Cuernavaca, Mexico · Active not recruiting
Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara, Mexico · Recruiting
Instituto Nacional de Pediatria (INP) (National Institute of Pediatrics)
Mexico City, Mexico · Recruiting
Uniwersytecki Szpital Kliniczny Im. Zamenhofa w Bialystoku
Bialystok, Poland · Not yet recruiting
Specjalistyczne Gabinety Sp. z o.o
Krakow, Poland · Active not recruiting
University Children Hospital
Krakow, Poland · Not yet recruiting
Polish Mother's Memorial Hospital Research Institute
Lodz, Poland · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.